{
    "clinical_study": {
        "@rank": "63848", 
        "arm_group": {
            "arm_group_label": "Lymphaticovenous Micro-Anastomosis", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study will assess the impact of lymphaticovenous microanastomosis in volume reduction\n      of postmastectomy upper extremity lymphedema. We hypothesize that multiple lymphaticovenous\n      micro-anastomosis in the distal arm will result in the reduction of volume and improvement\n      in quality of life of patients with post-mastectomy lymphedema"
        }, 
        "brief_title": "A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Lymphedema", 
            "Post Mastectomy"
        ], 
        "condition_browse": {
            "mesh_term": "Lymphedema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is 18-70 years of age\n\n          -  Subject is Stage II-IV unilateral lymphedema\n\n        Exclusion Criteria:\n\n          -  Subject is less than 6 months from completion of cancer treatment\n\n          -  Subject has allergic reaction to the lymphatic contrast agent (Indocyanine Blue)\n\n          -  Subject is medically unfit for the procedure\n\n          -  Subject is unable to complete the follow-up visits\n\n          -  Women with a positive urine pregnancy test are excluded from this study; women of\n             childbearing potential (defined as those who have not undergone a hysterectomy or who\n             have not been postmenopausal for at least 24 consecutive months) must agree to\n             refrain from breast feeding and practice adequate contraception as specified in the\n             informed consent. Adequate contraception consists of oral contraceptive, implantable\n             contraceptives, injectable contraceptives, a double barrier method, or abstinence.\n\n          -  Subject has bilateral lymphedema"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "7", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020837", 
            "org_study_id": "202676"
        }, 
        "intervention": {
            "arm_group_label": "Lymphaticovenous Micro-Anastomosis", 
            "intervention_name": "Lymphaticovenous Micro-Anastomosis", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "contact": {
                "email": "dewade@uams.edu", 
                "last_name": "Daisy Wade", 
                "phone": "501-686-8274"
            }, 
            "facility": {
                "address": {
                    "city": "Little Rock", 
                    "country": "United States", 
                    "state": "Arkansas", 
                    "zip": "72205"
                }, 
                "name": "University of Arkansas for Medical Sciences"
            }, 
            "investigator": [
                {
                    "last_name": "Mauricio Moreno, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "V. Suzanne Klimberg, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema", 
        "overall_contact": {
            "email": "mamoreno@uams.edu", 
            "last_name": "Mauricio Moreno, MD", 
            "phone": "501-686-7009"
        }, 
        "overall_official": {
            "affiliation": "University of Arkansas", 
            "last_name": "Mauricio Moreno, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Changes relative to baseline in the volume of the affected limb at 3 and 6 months from surgery", 
            "safety_issue": "No", 
            "time_frame": "3 and 6 months from surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020837"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Arkansas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Arkansas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}